66 studies found for:    Open Studies | "Papillomavirus Infections"
Show Display Options
Rank Status Study
21 Recruiting Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: carboplatin;   Radiation: radiation therapy;   Drug: paclitaxel;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
22 Recruiting Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Conditions: Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Procedure: infrared photocoagulation therapy;   Procedure: thermal ablation therapy;   Procedure: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
23 Recruiting Community-Driven Cervical Cancer Prevention in Western Kenya
Conditions: Human Papilloma Virus Infection;   Carcinoma in Situ of Uterine Cervix
Interventions: Behavioral: Community-based testing with standard linkage to care;   Behavioral: Community-based HPV testing with enhanced linkage to care
24 Recruiting Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Verrucous Carcinoma of the Larynx
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: intensity-modulated radiation therapy;   Procedure: quality-of-life assessment
25 Recruiting Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Procedure: therapeutic conventional surgery;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
26 Unknown  e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses
Conditions: Cervical Cancer;   Human Papilloma Virus Infection
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
27 Unknown  A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
Condition: Genital Human Papilloma Virus Infection
Intervention: Drug: Gardasil
28 Unknown  3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China
Condition: Anogenital Human Papilloma Virus Infection
Intervention:
29 Recruiting Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort
Condition: Human Papillomavirus-Related Cervical Carcinoma
Intervention: Other: Agreement between oral and cervical HPV infection
30 Unknown  Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection
Conditions: Acrochordon;   Skin Tag;   Soft Fibroma;   Human Papillomavirus;   HPV
Intervention:
31 Unknown  Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Condition: Papilloma Viral Infection
Intervention:
32 Unknown  Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)
Conditions: HPV Infection;   HIV Infection;   Syphilis
Intervention:
33 Recruiting Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand
Condition: HPV Testing
Intervention:
34 Recruiting Study of the Prevention of Anal Cancer
Conditions: Human Papillomavirus;   Cancer
Interventions: Procedure: Participants asked questions about recent experiences of anal intercourse in the last six months.;   Procedure: High Resolution Anoscopy
35 Recruiting The Clinical Relevance of P16INK4A Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.
Conditions: Recurrence;   Metastasis;   Death
Intervention:
36 Recruiting A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Condition: Condyloma
Interventions: Drug: AP611074 5% gel;   Drug: AP611074 matching placebo
37 Recruiting Avelumab for People With Recurrent Respiratory Papillomatosis
Conditions: Recurrent Respiratory Papillomatosis;   Juvenile Laryngeal Papilloma;   Laryngeal Papilloma, Recurrent;   Respiratory Papillomatosis;   Human Papilloma Virus
Intervention: Drug: Avelumab
38 Not yet recruiting Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Condition: Recurrent Respiratory Papillomatosis
Intervention: Drug: EF-022 (Modified Vitamin D Binding Protein Macrophage Activator)
39 Recruiting Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement
Condition: Recurrent Respiratory Papillomatosis
Intervention: Drug: Pembrolizumab
40 Recruiting Recurrent Respiratory Papillomatosis and Extraesophageal Reflux
Conditions: Recurrent Respiratory Papillomatosis;   Extra Oesophageal Reflux;   Laryngeal Cyst
Interventions: Procedure: Surgical collection of histology specimen;   Procedure: Performance of immunohistochemical analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years